FDA approves first mRNA-based flu vaccine

Дата публикации: 06-08-2026 11:34:46

The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said. “Flu remains a significant public health challenge, and mFLUSIVA provides an important new option for America’s seniors,” Moderna CEO Stephane Bancel said in a statement. “This approval also reflects the ongoing potential of our mRNA platform to help address important public health challenges through continued scientific innovation.” The new vaccine was found to be about 27% more effective during the 2024–25 respiratory virus season than standard flu shots in Moderna’s study, which enrolled over 40,000 adults...

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA approves first mRNA flu vaccine	0	5.78	06-08-2026
2	New Kind of Flu Shot Is on the Way as FDA Approves Moderna’s mRNA-Based Vaccine	0	10.21	06-08-2026
3	FDA approves first mRNA flu vaccine	0	5.78	06-08-2026
4	First mRNA-based flu vaccine approved by the FDA for older adults	0	11.83	06-08-2026
5	New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine	0	7.46	06-08-2026
6	FDA panel backs first-of-its-kind flu vaccine using mRNA technology	0	7	18-06-2026
7	FDA Approves mFLUSIVA (influenza vaccine, mRNA) for the Prevention of Seasonal Influenza	0	10.86	05-08-2026
8	The FDA Approved a New mRNA Flu Vaccine. Here’s What to Know	0	10.12	10-08-2026
9	Here’s what the first mRNA flu vaccine could mean for flu season	0	11.72	06-08-2026
10	Первая мРНК-вакцина от гриппа Moderna одобрена FDA	0	21.19	07-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.2. Источник: www.freerepublic.com.